{"id":"combivent","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL714","moleculeType":"Small molecule","molecularWeight":"239.31"},"aliases":["Bronchodilator","Ipratropium - Salbutamol"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"9832312e-0310-4ab6-8501-afa976fc7eb2","title":"COMBIVENT RESPIMAT (IPRATROPIUM BROMIDE AND ALBUTEROL) SPRAY, METERED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:30:34.563Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01969539","phase":"PHASE4","title":"Ventilator Adapters for Combivent Respimat","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2013-10-14","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":11},{"nctId":"NCT03405090","phase":"PHASE4","title":"Differential Mechanisms of Dyspnea Relief in Advanced COPD: Opiates vs. Bronchodilators","status":"COMPLETED","sponsor":"Dr. Denis O'Donnell","startDate":"2017-09-20","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":20},{"nctId":"NCT00388882","phase":"PHASE4","title":"Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-10-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":327},{"nctId":"NCT03029156","phase":"NA","title":"Effectiveness of the Aeroneb in Acute Severe Asthma","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2015-08","conditions":"Asthma Exacerbation","enrollment":31},{"nctId":"NCT01253473","phase":"PHASE4","title":"Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"National Jewish Health","startDate":"2012-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":46},{"nctId":"NCT01045174","phase":"NA","title":"Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma Patients","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2008-12","conditions":"Asthma","enrollment":180},{"nctId":"NCT02458482","phase":"NA","title":"Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2015-07","conditions":"Asthma","enrollment":""},{"nctId":"NCT03170232","phase":"PHASE2","title":"A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-10-16","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":54},{"nctId":"NCT03286855","phase":"NA","title":"Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Beaumont Hospital","startDate":"2017-10-18","conditions":"Chronic Obstructive Pulmonary Disease, COPD, Copd Exacerbation Acute","enrollment":62},{"nctId":"NCT02872597","phase":"PHASE1","title":"Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-09-05","conditions":"Status Asthmaticus","enrollment":30},{"nctId":"NCT02182869","phase":"PHASE2","title":"Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2001-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":7},{"nctId":"NCT02182674","phase":"PHASE2","title":"A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2000-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":66},{"nctId":"NCT02576626","phase":"PHASE4","title":"Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD","status":"COMPLETED","sponsor":"Wouter H. van Geffen","startDate":"2015-12","conditions":"COPD","enrollment":40},{"nctId":"NCT01331694","phase":"","title":"Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":76130},{"nctId":"NCT01332461","phase":"","title":"Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":5677},{"nctId":"NCT01337336","phase":"","title":"Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1},{"nctId":"NCT01381458","phase":"","title":"Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-09","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1936},{"nctId":"NCT01395875","phase":"","title":"Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-03","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":2849},{"nctId":"NCT01019694","phase":"PHASE3","title":"Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2009-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":470},{"nctId":"NCT02194205","phase":"PHASE3","title":"Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2000-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":360},{"nctId":"NCT02182856","phase":"PHASE4","title":"Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-02","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":33},{"nctId":"NCT02182700","phase":"PHASE3","title":"Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"1998-07","conditions":"Asthma","enrollment":47},{"nctId":"NCT02182713","phase":"PHASE4","title":"Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-05","conditions":"Asthma","enrollment":30},{"nctId":"NCT02173678","phase":"PHASE1","title":"Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1999-10","conditions":"Healthy","enrollment":12},{"nctId":"NCT02177253","phase":"PHASE3","title":"Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1118},{"nctId":"NCT00400153","phase":"PHASE3","title":"Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1480},{"nctId":"NCT00359788","phase":"PHASE4","title":"A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":349},{"nctId":"NCT00818454","phase":"PHASE2","title":"4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-12","conditions":"Asthma","enrollment":226},{"nctId":"NCT00096616","phase":"PHASE2","title":"Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-11","conditions":"Asthma","enrollment":113},{"nctId":"NCT00273962","phase":"PHASE4","title":"A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-05","conditions":"Asthma","enrollment":500},{"nctId":"NCT01655199","phase":"NA","title":"Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Laval University","startDate":"2012-09","conditions":"Moderate Chronic Obstructive Pulmonary Disease, Severe Chronic Obstructive Pulmonary Disease, Dyspnea","enrollment":40},{"nctId":"NCT00628758","phase":"PHASE3","title":"A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-12","conditions":"Asthma","enrollment":430},{"nctId":"NCT00393367","phase":"PHASE4","title":"Budesonide Inhalation Suspension for Acute Asthma in Children","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2006-12","conditions":"Asthma, Acute Asthma, Reactive Airway Exacerbation","enrollment":179},{"nctId":"NCT01360788","phase":"","title":"GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Laval University","startDate":"2009-02","conditions":"Mild Chronic Obstructive Pulmonary Disease, Respiratory Symptoms, Physical Activity","enrollment":53},{"nctId":"NCT00354354","phase":"PHASE4","title":"Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Queen's University","startDate":"2006-03","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":12},{"nctId":"NCT01243788","phase":"PHASE4","title":"The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2009-07","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":450}],"_emaApprovals":[],"_faersSignals":[{"count":4973,"reaction":"DYSPNOEA"},{"count":2736,"reaction":"DRUG INEFFECTIVE"},{"count":2193,"reaction":"OFF LABEL USE"},{"count":2035,"reaction":"PRODUCT QUALITY ISSUE"},{"count":1791,"reaction":"COUGH"},{"count":1750,"reaction":"PNEUMONIA"},{"count":1377,"reaction":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"count":1372,"reaction":"ASTHMA"},{"count":1083,"reaction":"NAUSEA"},{"count":1013,"reaction":"WHEEZING"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[{"date":"20160609","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20160415","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20150709","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20140619","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20130109","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20111007","type":"ORIG","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20160617","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20200927","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20160129","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20150309","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20141017","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20140814","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"},{"date":"20120829","type":"SUPPL","sponsor":"BOEHRINGER INGELHEIM","applicationNumber":"NDA021747"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":34,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Combivent","genericName":"Combivent","companyName":"Dr. Denis O'Donnell","companyId":"dr-denis-o-donnell","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}